Blue Dot News

One story a day from the frontier of human knowledge.

Medicine ·

Medicine

Brain's Waste Removal System Found Linked to Alzheimer's Disease

Researchers discovered that sleep helps clear brain waste, including Alzheimer's biomarkers, from the body.

Illustration: Blue Dot News

1 min read

Three years ago, researchers wondered if the same problem that plagued their sleep-deprived mice could be the source of human Alzheimer's disease. They turned their attention to a tiny network within our brains, called the glymphatic system. This delicate balance of blood vessels and waste removal is like a filter, cleaning up toxins from our brain tissue.

Imagine your brain as a crowded city at night – all those neurons are working hard, producing waste. But when you sleep, that waste begins to flow through the glymphatic system, like a slow-moving river, carrying away toxic proteins like amyloid beta and tau. Without this nightly cleanup, those toxins can build up, contributing to Alzheimer's disease. Now, researchers have caught a glimpse of how this system works in humans – using special equipment to monitor brain activity while participants slept.

The results are striking: when people got enough sleep, their glymphatic system was more active, clearing out those toxic proteins from the brain and into the bloodstream. This is like a crucial first step in preventing Alzheimer's disease from taking hold. The study suggests that enhancing this nightly cleanup could be a key strategy for slowing disease progression – a promising new approach to fighting one of humanity's most devastating brain diseases.

The people behind the work

  • Dagum P et al.

    Author

    Published in Nature communications

Source: Nature communications

Sources & Verification

Every statement in this story is drawn from the facts below. Each is linked to a primary or reputable source — follow any citation to check it for yourself.

  1. Dysfunction of the glymphatic system has been proposed as a mechanistic link between sleep disruption and Alzheimer's disease (AD). Nature communications
  2. In animal models, glymphatic impairment alone can drive AD pathology. Nature communications
  3. Whether this system clears amyloid beta (Aβ) and tau in humans remains unknown. Nature communications
  4. In a randomized crossover trial with 39 participants, we found that glymphatic clearance during normal sleep increased morning plasma levels of AD biomarkers compared to sleep deprivation. Nature communications
  5. Participants underwent overnight monitoring using an investigational device that measured dynamic changes in synaptic-metabolic release and glymphatic activity. Nature communications
  6. The observed changes mirrored predictions from a multicompartment model based on published data on Aβ and tau release and clearance. Nature communications
  7. Our findings indicate that sleep-active physiological processes, particularly reduced brain parenchymal resistance, enhance overnight glymphatic clearance of AD biomarkers to plasma. Nature communications
  8. These results support a key role for glymphatic function in AD pathophysiology and suggest its enhancement as a potential therapeutic strategy to slow disease progression. Nature communications

Part of the Blue Dot News 2026 retrospective — an archive reconstructed automatically from the published scientific record. The science is real and cited above; this is not original daily reporting, and it is deliberately kept out of the live news feed.

← All stories